XML 14 R3.htm IDEA: XBRL DOCUMENT v3.23.3Close
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2023
Jun. 30, 2023
Current assets    
Cash and cash equivalents $ 518 $ 367
Receivables, net 581 688
Inventories, net 710 696
Prepaid expenses and other current assets 102 77
Total current assets 1,911 1,828
Property, plant and equipment, net of accumulated depreciation and amortization of $2,768 and $2,705, respectively 1,317 1,345
Operating lease right-of-use assets 328 346
Goodwill 1,246 1,252
Trademarks, net 541 543
Other intangible assets, net 162 169
Other assets 486 462
Total assets 5,991 5,945 Close
Current liabilities    
Notes and loans payable 347 50
Current operating lease liabilities 88 87
Accounts payable and accrued liabilities 1,678 1,659
Income taxes payable 115 121
Total current liabilities 2,228 1,917
Long-term debt 2,478 2,477
Long-term operating lease liabilities 290 310
Other liabilities 837 825
Deferred income taxes 27 28
Total liabilities 5,860 5,557 Close
Commitments and contingencies
Stockholders’ equity    
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding 0 0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of September 30, 2023 and June 30, 2023; and 124,001,348 and 123,820,022 shares outstanding as of September 30, 2023 and June 30, 2023, respectively 131 131
Additional paid-in capital 1,246 1,245
Retained earnings 299 583
Treasury stock, at cost: 6,740,113 and 6,921,439 shares as of September 30, 2023 and June 30, 2023, respectively (1,219) (1,246)
Accumulated other comprehensive net (loss) income (494) (493)
Total Clorox stockholders’ (deficit) equity (37) 220
Noncontrolling interests 168 168
Total stockholders’ equity 131 388 Close
Total liabilities and stockholders’ equity $ 5,991 $ 5,945